Trial updates will help tailor endocrine therapy for premenopausal breast cancerJanuary 3, 2018Breast CancerPatient & Survivor Care
FDA: Gadolinium retention prompts new GBCA class warning, safety measuresDecember 21, 2017Neuro-oncologyPatient & Survivor Care
FDA: Gadolinium retention prompts new GBCA class warning, safety measuresDecember 20, 2017Patient & Survivor CareNeuro-oncologyCNS/Brain Cancer
Extra years of adjuvant bisphosphonate not needed in early breast cancerDecember 11, 2017Breast CancerPatient & Survivor Care
Ovarian suppression during breast cancer chemo helps stave off early menopause, preserve fertilityDecember 9, 2017Breast CancerPatient & Survivor Care
2 = 5 for additional AI therapy for postmenopausal HR+ breast cancerDecember 8, 2017Breast CancerPatient & Survivor Care
Acupuncture significantly reduces AI-associated arthralgiasDecember 8, 2017Breast CancerPatient & Survivor Care
VIDEO: 5 years of additional AI no better than 2 in HR+ breast cancerDecember 8, 2017Breast CancerPatient & Survivor Care
VIDEO: Dr. Matteo Lambertini answers questions on temporary ovarian suppressionDecember 7, 2017Breast CancerPatient & Survivor Care
ASCO platelet transfusion guidelines updatedDecember 4, 2017Leukemia, Myelodysplasia, TransplantationPatient & Survivor Care
Levofloxacin prophylaxis in AML reduces febrile neutropenia admissionsDecember 1, 2017Patient & Survivor Care
Cancer patients with TKI-induced hypothyroidism had better survival ratesNovember 15, 2017Patient & Survivor CareGastroenterologyLeukemia, Myelodysplasia, TransplantationLung CancerRenal Cell CarcinomaHead & Neck/Thyroid CancersBreast Cancer
